GoAI
Get started
Daito Pharmaceutical Co.,Ltd. logo

Daito Pharmaceutical Co.,Ltd.

4577.T

JPXHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

¥1,360

−¥3.00 · -0.22%

Aug 24, 3:30 PM JST

4577.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Daito Pharmaceutical Co.,Ltd. is a global entity primarily involved in the creation and sale of a diverse range of pharmaceutical products. Their offerings span active pharmaceutical ingredients (APIs) and chemical intermediates, alongside both prescription and over-the-counter (OTC) medications, and home-delivered medicines. These products are available in various formats, including tablets, capsules, lozenges, granules, and powdered forms. Beyond its own brand, the company also provides contract manufacturing services, developing medicinal formulations for other pharmaceutical firms. Additionally, Daito Pharmaceutical markets health food products. Established in 1942, it was initially known as Daito Corporation, changing to its current name in 1992, and maintains its headquarters in Toyama, Japan.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
JP
CEO
Hiroshi Matsumori
Listed since
Mar 24, 2010
Employees
1,073

Market position

Day range

Current ¥1,360

52-week range

Current ¥1,360

Open
¥1,358
Previous close
¥1,363
Volume
66.4K
0.8× average
Average volume
83.35K
Average daily volume
Market cap
39.09B JPY
Beta
0.19
Market reference 1
50-day average
¥1,261.96
+7.77% above average
200-day average
¥1,316.07
+3.34% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
42.55B JPY
P/E (TTM)
12.66×
P/B (TTM)
0.74×
P/S (TTM)
0.77×
EV / EBITDA
5.3×
Earnings yield
9.24%
Free cash flow yield
16.16%
Dividend yield
2.94%

Profitability & efficiency

Gross margin
19.54%
Operating margin
7.18%
Net margin
6.24%
Return on equity
5.98%
Return on assets
4.31%
Return on invested capital
4.48%

Financial health

Debt / equity
0.18×
Current ratio
2.62×
Altman Z-score
3.11
Piotroski F-score
9 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends28%19%10%2%Gross margin, FY2021: 26.01%Gross margin, FY2022: 22.52%Gross margin, FY2023: 20.63%Gross margin, FY2024: 16.73%Gross margin, FY2025: 19.54%Operating margin, FY2021: 15.11%Operating margin, FY2022: 11.56%Operating margin, FY2023: 8.30%Operating margin, FY2024: 5.18%Operating margin, FY2025: 7.18%Net margin, FY2021: 10.74%Net margin, FY2022: 7.98%Net margin, FY2023: 7.02%Net margin, FY2024: 3.77%Net margin, FY2025: 6.24%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 26.01%. Gross margin FY2022 22.52%. Gross margin FY2023 20.63%. Gross margin FY2024 16.73%. Gross margin FY2025 19.54%. Operating margin FY2021 15.11%. Operating margin FY2022 11.56%. Operating margin FY2023 8.30%. Operating margin FY2024 5.18%. Operating margin FY2025 7.18%. Net margin FY2021 10.74%. Net margin FY2022 7.98%. Net margin FY2023 7.02%. Net margin FY2024 3.77%. Net margin FY2025 6.24%.

Income trends

Revenue

50.65B JPY+0.01%

Operating income

3.64B JPY+38.76%

Net income

3.16B JPY+65.67%
Income trends across reported periods55.52B JPY36.03B JPY16.53B JPY−2.97B JPYRevenue, FY2021: 43.46B JPYRevenue, FY2022: 45.1B JPYRevenue, FY2023: 46.9B JPYRevenue, FY2024: 50.64B JPYRevenue, FY2025: 50.65B JPYOperating income, FY2021: 6.57B JPYOperating income, FY2022: 5.21B JPYOperating income, FY2023: 3.89B JPYOperating income, FY2024: 2.62B JPYOperating income, FY2025: 3.64B JPYNet income, FY2021: 4.67B JPYNet income, FY2022: 3.6B JPYNet income, FY2023: 3.29B JPYNet income, FY2024: 1.91B JPYNet income, FY2025: 3.16B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 43.46B JPY. Revenue FY2022 45.1B JPY. Revenue FY2023 46.9B JPY. Revenue FY2024 50.64B JPY. Revenue FY2025 50.65B JPY. Operating income FY2021 6.57B JPY. Operating income FY2022 5.21B JPY. Operating income FY2023 3.89B JPY. Operating income FY2024 2.62B JPY. Operating income FY2025 3.64B JPY. Net income FY2021 4.67B JPY. Net income FY2022 3.6B JPY. Net income FY2023 3.29B JPY. Net income FY2024 1.91B JPY. Net income FY2025 3.16B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue50.65B JPY50.64B JPY46.9B JPY45.1B JPY43.46B JPY
Cost of goods sold40.75B JPY42.17B JPY37.22B JPY34.95B JPY32.16B JPY
Gross profit9.9B JPY8.47B JPY9.67B JPY10.16B JPY11.31B JPY
Research and development—2.52B JPY2.35B JPY1.87B JPY1.75B JPY
Selling, general, and administrative6.26B JPY3.33B JPY3.43B JPY3.08B JPY2.99B JPY
Operating expenses6.26B JPY5.85B JPY5.78B JPY4.94B JPY4.74B JPY
Interest income1M JPY1M JPY———
Interest expense130M JPY123M JPY41M JPY12M JPY9M JPY
Depreciation and amortization4.39B JPY4.33B JPY3.66B JPY3.87B JPY3.31B JPY
Operating income3.64B JPY2.62B JPY3.89B JPY5.21B JPY6.57B JPY
Net income3.16B JPY1.91B JPY3.29B JPY3.6B JPY4.67B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
30.96

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates42.8831.2819.678.07Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Oct 11, 2024: actual 40.41, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Jan 10, 2025: actual 9.49, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 14, 2025: actual 10.17, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 11, 2025: actual 22.88, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 10, 2025: actual 23.24, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Jan 14, 2026: actual 18.08, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 10, 2026: actual 35.21, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 10, 2026: actual 30.96, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates14.84B13.49B12.14B10.8BQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Jan 10, 2025: actual 11.91B JPY, estimate 12.68B JPY, surprise -6.09%, Miss. Q2 2025, reported Apr 14, 2025: actual 12.03B JPY, estimate 11.37B JPY, surprise +5.80%, Beat. Q3 2025, reported Jul 11, 2025: actual 14.03B JPY, estimate 12.39B JPY, surprise +13.26%, Beat. Q4 2025, reported Oct 10, 2025: actual 13.01B JPY, estimate 13.3B JPY, surprise -2.17%, Miss. Q1 2026, reported Jan 14, 2026: actual 12.13B JPY, estimate 12.89B JPY, surprise -5.89%, Miss. Q2 2026, reported Apr 10, 2026: actual 11.59B JPY, estimate 12.56B JPY, surprise -7.71%, Miss. Q3 2026, reported Jul 10, 2026: actual 13.92B JPY, estimate 14.27B JPY, surprise -2.45%, Miss. Q4 2026, reported Oct 8, 2026: actual —, estimate 13.95B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥37.50

2025 complete year+16.2% since 2021

2026 partial: ¥20.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Nov 30, 2026

¥22.50

Semi-Annual

Record Nov 30, 2026 · Payment Nov 30, 2026

DividendUpcoming

Ex-dividend May 28, 2027

¥22.50

Semi-Annual

Record May 31, 2027 · Payment May 28, 2027

Dividend

Ex-dividend May 28, 2026

¥20.00

Semi-Annual

Record May 31, 2026 · Payment Aug 4, 2026

Dividend

Ex-dividend Nov 27, 2025

¥20.00

Semi-Annual

Record Nov 30, 2025 · Payment Feb 2, 2026

Dividend

Ex-dividend May 29, 2025

¥35.00

Semi-Annual

Record May 31, 2025 · Payment Aug 5, 2025

Dividend

Ex-dividend Nov 28, 2024

¥35.00

Semi-Annual

Record Nov 30, 2024 · Payment Feb 3, 2025

4577.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,973

-0.54%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,815

+0.88%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,975

+0.32%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406

+0.80%

ETFs holding 4577.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
81.51M
Weight
0.00%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥417.7-0.07%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
2.93M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.71+0.78%
Vanguard FTSE Developed Markets ETF logoVanguard FTSE Developed Markets ETFVEA
Market value
1.71M
Weight
0.00%
AUM
315B USD
Expense ratio
0.03%
Price / 1D
$73.42+0.80%
Avantis International Small Cap Value ETF logoAvantis International Small Cap Value ETFAVDV
Market value
1.68M
Weight
0.01%
AUM
20.24B USD
Expense ratio
0.36%
Price / 1D
$111.95+1.06%
Dimensional - International Small Cap Value ETF logoDimensional - International Small Cap Value ETFDISV
Market value
1.44M
Weight
0.03%
AUM
5.23B USD
Expense ratio
0.42%
Price / 1D
$44.49+0.86%
Vanguard FTSE All-World ex-US Small-Cap ETF logoVanguard FTSE All-World ex-US Small-Cap ETFVSS
Market value
699.43K
Weight
0.00%
AUM
13.6B USD
Expense ratio
0.06%
Price / 1D
$160.06+0.43%
Schwab International Small-Cap Equity ETF logoSchwab International Small-Cap Equity ETFSCHC
Market value
424.16K
Weight
0.01%
AUM
5.73B USD
Expense ratio
0.06%
Price / 1D
$51.25+0.61%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
393.8K
Weight
0.01%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.545+0.71%

Continue in GoAI

Research 4577.T

research.disclaimer